| ||||
The Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration recommended today that the FDA expand its approval of QLT PhotoTherapeutics Inc.'s PHOTOFRIN for Injection to include early-stage lung cancer. [PR Newswire]
Napro BioTherapeutics, Inc. Announces FDA Advisory Panel Recommendation For Approval of Anti-Cancer Drug PaxeneNaPro BioTherapeutics, Inc. today announced that the United States Food and Drug Administration's Oncologic Drugs Advisory Committee recommended by a unanimous vote that Paxene be approved by the FDA for use "after failure ... [Business Wire]IVAX PAXENE SAFETY "MAY BE BETTER THAN THAT OF TAXOL," the company asserted at a Sept. 19 meeting of FDA's Oncologic Drugs Advisory Committee to review the liposomal paclitaxel product for treatment of AIDS-related Kaposi's sarcoma. [Health News Daily]
|